Body Composition and Bone Mineral Density in Postmenopausal Women with Advanced Knee Osteoarthritis Undergoing Surgical Treatment
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study aimed to demonstrate the bone mineral density (BMD) and body composition in postmenopausal women with knee osteoarthritis (OA) who underwent surgical treatment, such as total knee arthroplasty, osteotomy, or meniscectomy.Methods: A total of 254 women with OA aged 50 years who underwent surgical treatment were enrolled in this study. We evaluated obesity-related factors, muscle components, and BMD using dual-energy X-ray absorptiometry.Results: No significant differences were noted in the BMD of the hip joint between the symptomatic side of the leg with knee OA and the contralateral side. However, when comparing the BMD of each component, the results indicated a significantly higher BMD in the obesity group based on body mass index (BMI). When defining sarcopenic obesity (SO) using various indicators of obesity (BMI, the estimated visceral adipose tissue area, android/gynoid ratio, and total body fat percentage), the prevalence of SO in the OA group who underwent surgical treatment ranged from 22.0% to 49.6%.Conclusions: This study investigated obesity-related factors in patients with advanced knee OA who underwent surgery, revealing a high prevalence of overweight/obese individuals, the presence of SO, and a complex relationship between obesity, body composition, and bone density, highlighting the potential protective effects of weight-bearing on bone health while exploring the impact of sarcopenia on bone density differences in the context of OA. Depending on various definitions of obesity, diverse proportions of SO in patients with OA have been observed, and further detailed research is required to understand its impact on the condition.
Abstract
Objectives: This study aimed to demonstrate the bone mineral density (BMD) and body composition in postmenopausal women with knee osteoarthritis (OA) who underwent surgical treatment, such as total knee arthroplasty, osteotomy, or meniscectomy.Methods: A total of 254 women with OA aged 50 years who underwent surgical treatment were enrolled in this study. We evaluated obesity-related factors, muscle components, and BMD using dual-energy X-ray absorptiometry.Results: No significant differences were noted in the BMD of the hip joint between the symptomatic side of the leg with knee OA and the contralateral side. However, when comparing the BMD of each component, the results indicated a significantly higher BMD in the obesity group based on body mass index (BMI). When defining sarcopenic obesity (SO) using various indicators of obesity (BMI, the estimated visceral adipose tissue area, android/gynoid ratio, and total body fat percentage), the prevalence of SO in the OA group who underwent surgical treatment ranged from 22.0% to 49.6%.Conclusions: This study investigated obesity-related factors in patients with advanced knee OA who underwent surgery, revealing a high prevalence of overweight/obese individuals, the presence of SO, and a complex relationship between obesity, body composition, and bone density, highlighting the potential protective effects of weight-bearing on bone health while exploring the impact of sarcopenia on bone density differences in the context of OA. Depending on various definitions of obesity, diverse proportions of SO in patients with OA have been observed, and further detailed research is required to understand its impact on the condition.
참고문헌 (27)
- Kaeberlein M, "Healthy aging : the ultimate preventative medicine", Science, 350, pp.1191~1193 (2015)
- Vollset SE, "Fertility, mortality, migration, and population scenarios for 195countries and territories from 2017 to 2100 : a forecasting analysis for the Global Burden of Disease Study", Lancet, 396, pp.1285~1306 (2020)
- WHO Scientific Group on the Burden of Musculoskeletal Conditions at the Start of the New Millennium, "The burden of musculoskeletal conditions at the start of the new millennium", World Health Organ Tech Rep Ser, 919, pp.1~218 (2003)
- Grazio S, "Osteoarthritis--epidemiology, economics and quality of life", Reumatizam, 52, pp.21~29 (2005)
- Cui A, "Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies", EClinicalMedicine, 29-30, pp.100587~ (2020)
- Health Insurance Review & Assessment Service, "National health insurance statistical yearbook" (2019), Health Insurance Review & Assessment Service;National Health Insurance Service; 2020
- Hunter DJ, "Osteoarthritis", Lancet, 393, pp.1745~1759 (2019)
- King LK, "Obesity & osteoarthritis", Indian J Med Res, 138, pp.185~193 (2013)
- Chen LK, "Asian Working Group for Sarcopenia : 2019 consensus update on sarcopenia diagnosis and treatment", J Am Med Dir Assoc, 21, pp.300~307 (2020)
- Pan WH, "How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment : an extension of Asian-Pacific recommendations", Asia Pac J Clin Nutr, 17, pp.370~374 (2008)
- Dickey RA, "AACE", ACE position statement on the prevention, diagnosis, and treatment of obesity(1998 revision), 1998, pp.4, 297~350
- Kelly TL, "Practical and technical advantages of DXA visceral fat assessment compared with computed tomography", Age, 36, pp.50~ (2010)
- Yang L, "Association of the android to gynoid fat ratio with nonalcoholic fatty liver disease : a crosssectional study", Front Nutr, 10, pp.1162079~ (2023)
- Kanis JA, "Assessment of osteoporosis at the primary health-care level" (2007), University of Sheffield
- Khaodhiar L, "Obesity and its comorbid conditions", Clin Cornerstone, 2, pp.17~31 (1999)
- Healy GN, "Objectively measured sedentary time, physical activity, and metabolic risk : the Australian Diabetes, Obesity and Lifestyle Study(AusDiab)", Diabetes Care, 31, pp.369~371 (2008)
- Barazzoni R, "Sarcopenic obesity : time to meet the challenge", Obes Facts, 11, pp.294~305 (2018)
- Donini LM, "Definition and diagnostic criteria for sarcopenic obesity : ESPEN and EASO consensus statement", Obes Facts, 15, pp.321~335 (2022)
- Murray CJ, "Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380, pp.2197~2223 (2012)
- Hootman JM, "Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040", Arthritis Rheumatol, 68, pp.1582~1587 (2016)
- "2016 elderly statistics" (2016)[URL]
- Bliddal H, "Osteoarthritis, obesity and weight loss : evidence, hypotheses and horizons-a scoping review", Obes Rev, 15, pp.578~586 (2014)
- Park CY, "Vitamin D in the prevention and treatment of osteoarthritis : from clinical interventions to cellular evidence", Nutrients, 11, pp.243~ (2019)
- McAlindon TE, "Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study", Ann Intern Med, 125, pp.353~359 (1996)
- Corti MC, "Epidemiology of osteoarthritis : prevalence, risk factors and functional impact", Aging Clin Exp Res, 15, pp.359~363 (2003)
- Hootman JM, "Health care provider counseling for physical activity or exercise among adults with arthritis-United States, 2002and 2014", MMWR Morb Mortal Wkly Rep, 66, pp.1398~1401 (2018)
- Georgiev T, "Modifiable risk factors in knee osteoarthritis : treatment implications", Rheumatol Int, 39, pp.1145~1157 (2019)